BDBM50226601 (2S)-2-[(2-aminoethyl)amino]-3-(1-methyl-1H-imidazol-4-yl)propanoic acid::CHEMBL235058
SMILES: Cn1cnc(C[C@H](NCCN)C(O)=O)c1
InChI Key: InChIKey=ZIGWTNNVVANKME-QMMMGPOBSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carboxypeptidase B2 isoform A (Homo sapiens (Human)) | BDBM50226601 ((2S)-2-[(2-aminoethyl)amino]-3-(1-methyl-1H-imidaz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | 235 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description Inhibition of human TAFIa | J Med Chem 50: 6095-103 (2007) Article DOI: 10.1021/jm0702433 BindingDB Entry DOI: 10.7270/Q2T153CG | |||||||||||
More data for this Ligand-Target Pair |